Variant report
Variant | esv3367802 |
---|---|
Chromosome Location | chr20:22813369-22813851 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs541291831 | chr20:22813419-22813420 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs545088614 | chr20:22813434-22813435 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs375048643 | chr20:22813479-22813480 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs563487022 | chr20:22813492-22813493 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs568077348 | chr20:22813537-22813538 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs369420948 | chr20:22813538-22813539 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs6137763 | chr20:22813563-22813564 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs61567760 | chr20:22813574-22813575 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs571081982 | chr20:22813609-22813610 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs185029880 | chr20:22813618-22813619 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs556592112 | chr20:22813636-22813637 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs148281432 | chr20:22813661-22813662 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs56000393 | chr20:22813686-22813687 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs560034994 | chr20:22813710-22813711 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs142931839 | chr20:22813713-22813714 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs58793559 | chr20:22813715-22813716 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs555865437 | chr20:22813722-22813723 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs572473182 | chr20:22813740-22813741 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540377102 | chr20:22813741-22813742 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs560100163 | chr20:22813814-22813815 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs56998281 | chr20:22813832-22813833 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs141524512 | chr20:22813835-22813836 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 16272173 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 19627613 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Central neurocytomas | 17123091 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Colorectal cancer | 21645411 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Autism | 22495311 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Alagille syndrome | 17576883 | CNVD |
Anaplastic large cell lymphoma | 18179710 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Cancer | 21183584 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Pancreatic endocrine tumor | 17639061 | CNVD |
Breast cancer | 16608533 | CNVD |
Cancer | 20164919 | CNVD |
Bladder cancer | 21909424 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Breast cancer | 17133270 | CNVD |
Thrombophilia | 17576883 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Mental retardation | 21062444 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
Chordoma | 18071362 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr20:22806200-22814000 | Weak transcription | A549 | lung |
2 | chr20:22808800-22814600 | Weak transcription | Primary hematopoietic stem cells short term culture | blood |
3 | chr20:22809000-22813400 | Weak transcription | K562 | blood |
4 | chr20:22809000-22816000 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
5 | chr20:22809400-22816200 | Weak transcription | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr20:22809600-22814400 | Weak transcription | Placenta Amnion | Placenta Amnion |
7 | chr20:22809600-22816200 | Weak transcription | NHEK | skin |
8 | chr20:22810200-22816000 | Weak transcription | Breast Myoepithelial Primary Cells | Breast |
9 | chr20:22813200-22815400 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
10 | chr20:22813400-22814200 | Enhancers | K562 | blood |